Targeted therapies of solid cancers
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference58 articles.
1. BRIM-3 Study GroupImproved survival with vemurafenib in melanoma with BRAF V600E mutation.;Chapman;N Engl J Med,2011
2. Anaplastic lymphoma kinase inhibition in nonsmall-cell lung cancer.;Kwak;N Engl J Med,2010
3. The BATTLE trial: personalizing therapy for lung cancer.;Kim;Cancer Discov,2011
4. Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative.;Tsimberidou;Clin Cancer Res,2012
5. The variability of estrogen receptors in metastatic breast cancer.;Brennan;Am J Surg,1979
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes;Lung Cancer - Modern Multidisciplinary Management;2021-06-02
2. The Relevance of Genetic Factors in Tumor Therapy and the Underlying Pharmacogenetic Principles;Cancer Genetics and Psychotherapy;2017
3. Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine;Oncotarget;2016-12-15
4. The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?;Journal of Cellular Physiology;2016-11-20
5. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment – have we fallen short of the promise?;Current Opinion in Oncology;2016-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3